<DOC>
	<DOCNO>NCT00318552</DOCNO>
	<brief_summary>This study directly compare meropenem standard first line antibiotic therapy subject enter ICU secondary nosocomial sepsis , contract sepsis resident ICU .</brief_summary>
	<brief_title>Pharmacoeconomic Analysis First Line Meropenem Versus Standard Antibiotic Treatment Seriously Infected Secondary Nosocomial Sepsis Syndrome Patients .</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Systemic Inflammatory Response Syndrome</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Meropenem</mesh_term>
	<mesh_term>Thienamycins</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>Male female subject age â‰¥ 18 , require intensive care treatment relate secondary nosocomial sepsis , require potent broad spectrum intravenous antibiotic therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Antibiotic Therapy</keyword>
	<keyword>sepsis treatment</keyword>
	<keyword>Meropenem</keyword>
</DOC>